Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 4Unknown 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 111Neoplasms 8Neoplasm Metastasis 6Carcinoma, Intraductal, Noninfiltrating 6Breast Carcinoma In Situ 4Arthralgia 4Advanced Breast Cancer 4Osteoporosis 2Multiple Endocrine Neoplasia Type 1 2Breast Neoplasms, Male 2Breast Cancer Metastatic 2Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Seizures 1Recurrence 1Quality of Life 1Patient Compliance 1Pain 1Ovarian Neoplasms 1Obesity 1Lethal Congenital Contracture Syndrome 2 1Joint Diseases 1Invasive Breast Cancer 1Hypogonadism 1Granulosa Cell Ovarian Cancer 1Fractures, Bone 1Erectile Dysfunction 1Epilepsy 1Bone Diseases, Metabolic 1Bone Density 1

Interventions

Fulvestrant 5Anastrozole 4Letrozole 3Docetaxel 2Dasatinib 2vandetanib 1sonidegib 1ribociclib 1pembrolizumab 1palbociclib 1olaparib 1irinotecan sucrosofate 1exemestane 1cediranib 1XMT-1522 1Vorinostat 1Tablets 1Ritonavir 1Population Groups 1Paclitaxel 1Moxifloxacin 1Itraconazole 1Histone Deacetylase Inhibitors 1Gemcitabine 1FCN-437c 1Everolimus 1Electroporation 1Cryosurgery 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Advanced Breast Cancer × Anastrozole × Clear all
NCT07225790 2026-05-12

Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases

Brigham and Women's Hospital

Completed
3,883 enrolled
Breast

Advanced Breast Cancer

NCT00562458 2013-02-05

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

AstraZeneca

Completed
200 enrolled
Breast

Advanced Breast Cancer

NCT00327769 2011-01-25

Faslodex Advanced Breast Cancer Local Chinese Study

AstraZeneca

Phase 3 Completed
234 enrolled
Breast

Advanced Breast Cancer

NCT00635713 2009-04-10

Second Line Breast Cancer Trial

AstraZeneca

Phase 3 Completed
588 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡